{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T12:48:59Z","timestamp":1792586939128,"version":"4.5.0"},"reference-count":69,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,6,11]],"date-time":"2027-06-11T00:00:00Z","timestamp":1812672000000},"content-version":"am","delay-in-days":345,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007812","name":"University of Washington","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007812","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007268","name":"Washington University in St Louis","doi-asserted-by":"publisher","award":["12-3271-93128"],"award-info":[{"award-number":["12-3271-93128"]}],"id":[{"id":"10.13039\/100007268","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006775","name":"GE Healthcare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006775","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017540","name":"National Heart Lung and Blood Institute Division of Intramural Research","doi-asserted-by":"publisher","award":["1R01HL142297-01A1"],"award-info":[{"award-number":["1R01HL142297-01A1"]}],"id":[{"id":"10.13039\/100017540","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Nuclear Medicine"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1053\/j.semnuclmed.2026.05.006","type":"journal-article","created":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T04:02:38Z","timestamp":1780372958000},"page":"651-663","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["18F-FDG -PET\/CT in cardiac sarcoidosis: Diagnosis, therapy monitoring, and future directions"],"prefix":"10.1053","volume":"56","author":[{"given":"Bhargavi","family":"Sovani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shubha G.","family":"Ravindra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cylen","family":"Javidan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farrokh","family":"Dehdashti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2141-7716","authenticated-orcid":false,"given":"Thomas H.","family":"Schindler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7983-4117","authenticated-orcid":false,"given":"Ashwin Singh","family":"Parihar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.semnuclmed.2026.05.006_bib0001","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1093\/eurheartj\/ehad067","article-title":"Cardiac sarcoidosis: phenotypes, diagnosis, treatment, and prognosis","volume":"44","author":"Lehtonen","year":"2023","journal-title":"Eur Hear J"},{"key":"10.1053\/j.semnuclmed.2026.05.006_bib0002","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jacc.2016.03.605","article-title":"Cardiac sarcoidosis","volume":"68","author":"Birnie","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.semnuclmed.2026.05.006_bib0003","doi-asserted-by":"crossref","first-page":"78","DOI":"10.14797\/mdcvj.1057","article-title":"Epidemiology, pathogenesis, and diagnosis of cardiac sarcoidosis","volume":"18","author":"Mathai","year":"2022","journal-title":"Methodist DeBakey Cardiovasc J"},{"key":"10.1053\/j.semnuclmed.2026.05.006_bib0004","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.jacc.2020.06.038","article-title":"Long-term adverse cardiac outcomes in patients with sarcoidosis","volume":"76","author":"Yafasova","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.semnuclmed.2026.05.006_bib0005","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0953-6205(03)00076-1","article-title":"Sarcoidosis: benefits of a multidisciplinary approach","volume":"14","author":"Drent","year":"2003","journal-title":"Eur J Intern Med"},{"key":"10.1053\/j.semnuclmed.2026.05.006_bib0006","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1007\/s12350-017-0978-9","article-title":"Joint SNMMI\u2013ASNC expert consensus document on the role of 18F-FDG PET\/CT in cardiac sarcoid detection and therapy monitoring","volume":"24","author":"Chareonthaitawee","year":"2017","journal-title":"J Nucl Cardiol"},{"key":"10.1053\/j.semnuclmed.2026.05.006_bib0007","doi-asserted-by":"crossref","first-page":"e1197","DOI":"10.1161\/CIR.0000000000001240","article-title":"Diagnosis and management of cardiac sarcoidosis: a scientific statement from the American Heart Association","volume":"149","author":"Cheng","year":"2024","journal-title":"Circulation"},{"key":"10.1053\/j.semnuclmed.2026.05.006_bib0008","article-title":"Evaluation of known or suspected cardiac sarcoidosis","volume":"9","author":"Blankstein","year":"2016","journal-title":"Circ: Cardiovasc Imaging"},{"key":"10.1053\/j.semnuclmed.2026.05.006_bib0009","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.hrthm.2014.03.043","article-title":"HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis","volume":"11","author":"Birnie","year":"2014","journal-title":"Hear Rhythm"},{"key":"10.1053\/j.semnuclmed.2026.05.006_bib0010","first-page":"19","article-title":"The WASOG Sarcoidosis Organ Assessment Instrument: an update of a previous clinical tool","volume":"31","author":"Judson","year":"2014","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1053\/j.semnuclmed.2026.05.006_bib0011","first-page":"949","article-title":"Advances in imaging for diagnosis and management of cardiac sarcoidosis","volume":"16","author":"Aggarwal","year":"2015","journal-title":"Eur Hear J - Cardiovasc Imaging"},{"key":"10.1053\/j.semnuclmed.2026.05.006_bib0012","doi-asserted-by":"crossref","DOI":"10.1136\/heartjnl-2025-326694","article-title":"Advanced cardiac imaging in cardiac sarcoidosis: current evidence and future directions","author":"Aslam","year":"2026","journal-title":"Heart"},{"key":"10.1053\/j.semnuclmed.2026.05.006_bib0013","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1001\/jamacardio.2022.2981","article-title":"Cardiovascular magnetic resonance imaging phenotypes and long-term outcomes in patients with suspected cardiac sarcoidosis","volume":"7","author":"Athwal","year":"2022","journal-title":"JAMA Cardiol"},{"key":"10.1053\/j.semnuclmed.2026.05.006_bib0014","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/s12350-017-1043-4","volume":"25","author":"Slart","year":"2018","journal-title":"J Nucl Cardiol"},{"key":"10.1053\/j.semnuclmed.2026.05.006_bib0015","article-title":"Complementary value of cardiac magnetic resonance imaging and positron emission tomography\/computed tomography in the assessment of cardiac sarcoidosis","volume":"11","author":"Vita","year":"2018","journal-title":"Circ: Cardiovasc Imaging"},{"key":"10.1053\/j.semnuclmed.2026.05.006_bib0016","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.222483","article-title":"Prognostic value of cardiac MRI and FDG PET in cardiac sarcoidosis: a systematic review and meta-analysis","volume":"307","author":"Aitken","year":"2023","journal-title":"Radiology"},{"key":"10.1053\/j.semnuclmed.2026.05.006_bib0017","first-page":"345","article-title":"Prognostic value of late gadolinium enhancement detected on cardiac magnetic resonance in cardiac sarcoidosis","volume":"16","author":"Stevenson","year":"2023","journal-title":"JACC: Cardiovasc Imaging"},{"key":"10.1053\/j.semnuclmed.2026.05.006_bib0018","first-page":"104","article-title":"Possible causes and clinical relevance of a \u201cring-like\u201d late gadolinium enhancement pattern","volume":"17","author":"Bietenbeck","year":"2024","journal-title":"JACC: Cardiovasc Imaging"},{"key":"10.1053\/j.semnuclmed.2026.05.006_bib0019","first-page":"40","article-title":"T1-Mapping and outcome in nonischemic cardiomyopathy all-cause mortality and heart failure","volume":"9","author":"Puntmann","year":"2016","journal-title":"JACC: Cardiovasc Imaging"},{"key":"10.1053\/j.semnuclmed.2026.05.006_bib0020","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s41824-021-00119-w","article-title":"Combined simultaneous FDG-PET\/MRI with T1 and T2 mapping as an imaging biomarker for the diagnosis and prognosis of suspected cardiac sarcoidosis","volume":"5","author":"Cheung","year":"2021","journal-title":"Eur J Hybrid Imaging"},{"key":"10.1053\/j.semnuclmed.2026.05.006_bib0021","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s12968-020-00627-x","article-title":"Cardiovascular magnetic resonance native T2 and T2* quantitative values for cardiomyopathies and heart transplantations: a systematic review and meta-analysis","volume":"22","author":"Snel","year":"2020","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1053\/j.semnuclmed.2026.05.006_bib0022","first-page":"157","article-title":"Myocardial blood flow and inflammatory cardiac sarcoidosis","volume":"10","author":"Kruse","year":"2017","journal-title":"JACC: Cardiovasc Imaging"},{"key":"10.1053\/j.semnuclmed.2026.05.006_bib0023","doi-asserted-by":"crossref","first-page":"79","DOI":"10.17996\/ANC.01.01.79","article-title":"Role of PET\/CT for the identification of cardiac sarcoid disease","volume":"1","author":"Schindler","year":"2015","journal-title":"Ann Nucl Cardiol"},{"key":"10.1053\/j.semnuclmed.2026.05.006_bib0024","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jacc.2013.09.022","article-title":"Cardiac positron emission tomography enhances prognostic assessments of patients with suspected Cardiac sarcoidosis","volume":"63","author":"Blankstein","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.semnuclmed.2026.05.006_bib0025","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s12350-016-0502-7","article-title":"Patient preparation for cardiac fluorine-18 fluorodeoxyglucose positron emission tomography imaging of inflammation","volume":"24","author":"Osborne","year":"2017","journal-title":"J Nucl Cardiol"},{"key":"10.1053\/j.semnuclmed.2026.05.006_bib0026","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2214\/AJR.08.2081","article-title":"Brown fat: atypical locations and appearances encountered in PET\/CT","volume":"193","author":"Paidisetty","year":"2009","journal-title":"Am J Roentgenol"},{"key":"10.1053\/j.semnuclmed.2026.05.006_bib0027","doi-asserted-by":"crossref","first-page":"42","DOI":"10.17996\/anc.17-00042","article-title":"New guidelines for diagnosis of cardiac sarcoidosis in Japan","volume":"3","author":"Terasaki","year":"2017","journal-title":"Ann Nucl Cardiol"},{"key":"10.1053\/j.semnuclmed.2026.05.006_bib0028","article-title":"Clinical cases in the diagnosis of cardiac sarcoidosis","volume":"30","author":"Khoo","year":"2025","journal-title":"JACC: Case Rep"},{"key":"10.1053\/j.semnuclmed.2026.05.006_bib0030","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1007\/s12350-015-0160-1","article-title":"Infectious myocarditis on FDG-PET imaging mimicking sarcoidosis","volume":"22","author":"Sperry","year":"2015","journal-title":"J Nucl Cardiol"},{"key":"10.1053\/j.semnuclmed.2026.05.006_bib0031","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1055\/s-0041-1739379","article-title":"Cardiac tuberculosis on 18 F-FDG PET imaging\u2014A great masquerader of cardiac sarcoidosis","volume":"31","author":"Sundaraiya","year":"2021","journal-title":"Indian J Radiol Imaging"},{"key":"10.1053\/j.semnuclmed.2026.05.006_bib0032","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jacc.2022.10.021","article-title":"Genetic cardiomyopathy masquerading as cardiac sarcoidosis","volume":"81","author":"Lal","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.semnuclmed.2026.05.006_bib0033","first-page":"2347","article-title":"Genetic cardiomyopathy mimicking isolated cardiac sarcoidosis: diagnostic challenges with positron emission tomography","volume":"12","author":"Nishijo","year":"2025"},{"key":"10.1053\/j.semnuclmed.2026.05.006_bib0034","first-page":"583","article-title":"Genetic cardiomyopathies misdiagnosed as cardiac sarcoidosis","volume":"10","author":"Subramanian","year":"2024","journal-title":"JACC: Clin Electrophysiol"},{"key":"10.1053\/j.semnuclmed.2026.05.006_bib0035","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1007\/s12350-021-02886-2","article-title":"18F-FDG\/13N-ammonia cardiac PET findings in ATTR cardiac amyloidosis","volume":"30","author":"Young","year":"2023","journal-title":"J Nucl Cardiol"},{"key":"10.1053\/j.semnuclmed.2026.05.006_bib0036","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/j.amjcard.2015.08.025","article-title":"F-18-fluorodeoxyglucose positron emission tomography-guided sampling of mediastinal lymph nodes in the diagnosis of cardiac sarcoidosis","volume":"116","author":"Simonen","year":"2015","journal-title":"Am J Cardiol"},{"key":"10.1053\/j.semnuclmed.2026.05.006_bib0037","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1056\/NEJMra071714","volume":"357","author":"Iannuzzi","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semnuclmed.2026.05.006_bib0038","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.amjcard.2023.06.101","article-title":"An international survey of current clinical practice in the treatment of cardiac sarcoidosis","volume":"203","author":"Bortoli","year":"2023","journal-title":"Am J Cardiol"},{"key":"10.1053\/j.semnuclmed.2026.05.006_bib0039","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/S0002-9149(01)01978-6","article-title":"Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone","volume":"88","author":"Yazaki","year":"2001","journal-title":"Am J Cardiol"},{"key":"10.1053\/j.semnuclmed.2026.05.006_bib0040","first-page":"706","article-title":"High-dose intravenous glucocorticoids are effective in the acute management of ventricular arrhythmias in cardiac sarcoidosis: a case series","volume":"6","author":"Slivnick","year":"2020","journal-title":"Hear Case Rep"},{"key":"10.1053\/j.semnuclmed.2026.05.006_bib0041","first-page":"536","article-title":"Intravenous methylprednisolone for ventricular tachycardia electrical storm in cardiac sarcoidosis case series and 1-year follow-up","volume":"7","author":"Kafil","year":"2021","journal-title":"JACC: Clin Electrophysiol"},{"key":"10.1053\/j.semnuclmed.2026.05.006_bib0042","article-title":"Long-term corticosteroid-sparing immunosuppression for cardiac sarcoidosis","volume":"8","author":"Rosenthal","year":"2019","journal-title":"J Am Hear Assoc"},{"key":"10.1053\/j.semnuclmed.2026.05.006_bib0043","article-title":"Steroid sparing immunosuppression in management of cardiac sarcoidosis: a systematic review","volume":"4","author":"Roshankar","year":"2022","journal-title":"Heal Sci Rev"},{"key":"10.1053\/j.semnuclmed.2026.05.006_bib0044","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1161\/01.CIR.0000077913.60364.D2","article-title":"Double-blind, placebo-controlled, pilot trial of Infliximab, a chimeric monoclonal antibody to Tumor necrosis Factor-\u03b1, in patients with moderate-to-severe heart failure","volume":"107","author":"Chung","year":"2003","journal-title":"Circulation"},{"key":"10.1053\/j.semnuclmed.2026.05.006_bib0045","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.04079-2020","article-title":"ERS clinical practice guidelines on treatment of sarcoidosis","volume":"58","author":"Baughman","year":"2021","journal-title":"Eur Respir J"},{"key":"10.1053\/j.semnuclmed.2026.05.006_bib0046","first-page":"45","article-title":"Prospective analysis of immunosuppressive therapy in cardiac sarcoidosis with fluorodeoxyglucose myocardial accumulation the PRESTIGE study","volume":"17","author":"Morimoto","year":"2024","journal-title":"JACC: Cardiovasc Imaging"},{"key":"10.1053\/j.semnuclmed.2026.05.006_bib0047","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s12350-016-0682-1","article-title":"The role of serial FDG PET for assessing therapeutic response in patients with cardiac sarcoidosis","volume":"24","author":"Lee","year":"2017","journal-title":"J Nucl Cardiol"},{"key":"10.1053\/j.semnuclmed.2026.05.006_bib0048","first-page":"1280","article-title":"Effect of corticosteroid dose and duration on 18-fluorodeoxyglucose positron emission tomography in cardiac sarcoidosis","volume":"13","author":"Okada","year":"2020","journal-title":"JACC: Cardiovasc Imaging"},{"key":"10.1053\/j.semnuclmed.2026.05.006_bib0049","doi-asserted-by":"crossref","first-page":"5808","DOI":"10.3390\/jcm10245808","article-title":"Advances in diagnostic imaging for cardiac sarcoidosis","volume":"10","author":"Manabe","year":"2021","journal-title":"J Clin Med"},{"key":"10.1053\/j.semnuclmed.2026.05.006_bib0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.nuclcard.2024.102088","article-title":"Quantification of metabolic activity in the evaluation of cardiac sarcoidosis","volume":"43","author":"Wiefels","year":"2025","journal-title":"J Nucl Cardiol"},{"key":"10.1053\/j.semnuclmed.2026.05.006_bib0051","first-page":"1079","article-title":"Risk stratification in cardiac sarcoidosis with cardiac positron emission tomography A systematic review and meta-analysis","volume":"17","author":"Kafil","year":"2024","journal-title":"JACC: Cardiovasc Imaging"},{"key":"10.1053\/j.semnuclmed.2026.05.006_bib0052","first-page":"411","article-title":"Hybrid magnetic resonance positron emission tomography is associated with cardiac-related outcomes in cardiac sarcoidosis","volume":"17","author":"Trivieri","year":"2024","journal-title":"JACC: Cardiovasc Imaging"},{"key":"10.1053\/j.semnuclmed.2026.05.006_bib0053","doi-asserted-by":"crossref","DOI":"10.1186\/s41824-017-0014-y","article-title":"Somatostatin receptor based hybrid imaging in sarcoidosis","volume":"1","author":"Slart","year":"2017","journal-title":"Eur J Hybrid Imaging"},{"key":"10.1053\/j.semnuclmed.2026.05.006_bib0054","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1046\/j.1365-2362.1999.00498.x","article-title":"Immunohistochemical localization of somatostatin receptor sst2A in sarcoid granulomas","volume":"29","author":"Bokum","year":"1999","journal-title":"Eur J Clin Investig"},{"key":"10.1053\/j.semnuclmed.2026.05.006_bib0055","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1007\/s12350-019-01782-0","article-title":"Feasibility of somatostatin receptor-targeted imaging for detection of myocardial inflammation: a pilot study","volume":"28","author":"Bravo","year":"2021","journal-title":"J Nucl Cardiol"},{"key":"10.1053\/j.semnuclmed.2026.05.006_bib0056","doi-asserted-by":"crossref","first-page":"77807","DOI":"10.18632\/oncotarget.12799","article-title":"Somatostatin receptor based PET\/CT in patients with the suspicion of cardiac sarcoidosis: an initial comparison to cardiac MRI","volume":"7","author":"Lapa","year":"2016","journal-title":"Oncotarget"},{"key":"10.1053\/j.semnuclmed.2026.05.006_bib0057","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1007\/s12149-021-01641-4","article-title":"Comparison of 68Ga-DOTANOC PET\/CT with cardiac MRI in patients with clinical suspicion of cardiac sarcoidosis","volume":"35","author":"Kaushik","year":"2021","journal-title":"Ann Nucl Med"},{"key":"10.1053\/j.semnuclmed.2026.05.006_bib0058","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/s43055-025-01582-2","article-title":"Somatostatin receptor imaging with Ga-68 DOTANOC PET\/CT in the response assessment of cardiac sarcoidosis","volume":"56","author":"Narmatha","year":"2025","journal-title":"Egypt J Radiol Nucl Med"},{"key":"10.1053\/j.semnuclmed.2026.05.006_bib0059","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1007\/s12350-022-03111-4","article-title":"Potential clinical utility of 68Ga-DOTATATE PET\/CT for detection and response assessment in cardiac sarcoidosis","volume":"30","author":"Lee","year":"2023","journal-title":"J Nucl Cardiol"},{"key":"10.1053\/j.semnuclmed.2026.05.006_bib0060","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.3390\/diagnostics13081450","article-title":"In Vivo fibroblast activation of systemic sarcoidosis: a 68Ga-FAPI-04 PET\/CT imaging study","volume":"13","author":"Wang","year":"2023","journal-title":"Diagnostics"},{"key":"10.1053\/j.semnuclmed.2026.05.006_bib0061","doi-asserted-by":"crossref","first-page":"e278","DOI":"10.1097\/RLU.0000000000005214","article-title":"Intense 68Ga-OncoFAP uptake as a new promising diagnostic biomarker in cardiac sarcoidosis","volume":"49","author":"Ventura","year":"2024","journal-title":"Clin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2026.05.006_bib0062","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1007\/s12350-020-02307-w","article-title":"Cardiac fibroblast activation detected by Ga-68 FAPI PET imaging as a potential novel biomarker of cardiac injury\/remodeling","volume":"28","author":"Siebermair","year":"2021","journal-title":"J Nucl Cardiol"},{"key":"10.1053\/j.semnuclmed.2026.05.006_bib0063","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s13550-020-00742-x","article-title":"FLT-PET for the assessment of systemic sarcoidosis including cardiac and CNS involvement: a prospective study with comparison to FDG-PET","volume":"10","author":"Martineau","year":"2020","journal-title":"EJNMMI Res"},{"key":"10.1053\/j.semnuclmed.2026.05.006_bib0064","first-page":"2280","article-title":"Imaging cardiac sarcoidosis with FLT-PET compared with FDG\/perfusion-PET A prospective pilot study","volume":"12","author":"Martineau","year":"2019","journal-title":"JACC: Cardiovasc Imaging"},{"key":"10.1053\/j.semnuclmed.2026.05.006_bib0065","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s13550-017-0321-0","article-title":"Comparative evaluation of 18F-FLT and 18F-FDG for detecting cardiac and extra-cardiac thoracic involvement in patients with newly diagnosed sarcoidosis","volume":"7","author":"Norikane","year":"2017","journal-title":"EJNMMI Res"},{"key":"10.1053\/j.semnuclmed.2026.05.006_bib0066","doi-asserted-by":"crossref","first-page":"161","DOI":"10.62347\/NANX3492","article-title":"Current uses and understanding of PET imaging in cardiac sarcoidosis","volume":"14","author":"Madiraju","year":"2024","journal-title":"Am J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2026.05.006_bib0067","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1007\/s12350-019-01976-6","article-title":"18F-FMISO PET\/CT detects hypoxic lesions of cardiac and extra-cardiac involvement in patients with sarcoidosis","volume":"28","author":"Furuya","year":"2021","journal-title":"J Nucl Cardiol"},{"key":"10.1053\/j.semnuclmed.2026.05.006_bib0068","first-page":"457","article-title":"Another step toward integrated MR\/PET as favored imaging modality in cardiac sarcoidosis \u2217","volume":"15","author":"Schindler","year":"2022","journal-title":"JACC: Cardiovasc Imaging"},{"key":"10.1053\/j.semnuclmed.2026.05.006_bib0069","first-page":"122","article-title":"Advanced imaging in cardiac sarcoidosis","volume":"40","author":"Ramirez","year":"2019","journal-title":"Chin J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2026.05.006_bib0070","first-page":"445","article-title":"Hybrid cardiac Magnetic resonance\/fluorodeoxyglucose positron emission tomography to differentiate active from chronic cardiac sarcoidosis","volume":"15","author":"Greulich","year":"2022","journal-title":"JACC: Cardiovasc Imaging"}],"container-title":["Seminars in Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001299826001133?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001299826001133?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T12:32:20Z","timestamp":1792585940000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001299826001133"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":69,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S0001299826001133"],"URL":"https:\/\/doi.org\/10.1053\/j.semnuclmed.2026.05.006","relation":{},"ISSN":["0001-2998"],"issn-type":[{"value":"0001-2998","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"18F-FDG -PET\/CT in cardiac sarcoidosis: Diagnosis, therapy monitoring, and future directions","name":"articletitle","label":"Article Title"},{"value":"Seminars in Nuclear Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.semnuclmed.2026.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}